Boditech Med Inc. (KOSDAQ:A206640) announces a share repurchase program. Under the program, the company will repurchase KRW 3,000 million under the contract with Daishin Securities Co., Ltd. The purpose of the program is to improve shareholder value and to stabilize stock price. The program will be valid until March 5, 2022. As of September 5, 2021, the company had 574,012 shares in treasury under the dividend capacity and 7,670 shares in treasury under other capacities.